-+ 0.00%
-+ 0.00%
-+ 0.00%

20/20 BIOLABS SHARES UP 19.5% AT $1.44 PREMARKET AFTER CO'S PLANS FOR EBOLA, HANTAVIRUS TESTING PREPAREDNESS

Reuters·05/22/2026 13:02:54

Please log in to view news